Tropicamide
You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.
| Image:Tropicamide.svg | |
| Tropicamide
| |
| Systematic (IUPAC) name | |
| N-ethyl-3-hydroxy-2-phenyl-N- (pyridin-4-ylmethyl) propanamide | |
| Identifiers | |
| CAS number | |
| ATC code | S01 |
| PubChem | |
| DrugBank | |
| Chemical data | |
| Formula | C17H20N2O2 |
| Mol. mass | 284.353 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Protein binding | 45% |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Tropicamide (troe-PIK-a-mide) is a muscarinic acetylcholine receptor blocker. It is used to dilate (enlarge) the pupil of the eye in order to allow better examination of the lens, vitreous humor, and retina. Due to its relatively short duration of effect (4 - 8 hours), it is typically used during eye examinations, but may also be used before or after eye surgery.
Application of tropicamide produces short acting mydriasis (dilation) and cycloplegia. Systemic side effects are very rare, although loss of consciousness has been reported in a ten-year-old child after administration of tropicamide eyedrops.[citation needed]
Tropicamide, a parasympatholytic, is occasionally administered in eye drops in combination with p-hydroxyamphetamine (brand name Paremyd), which is a sympathomimetic. The use of drugs stimulating multiple divisions of the autonomic nervous system ensures the dilation the pupil without opposing muscle group firing.
Other brand names include Mydriacyl.
See also

